FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Lehrstuhl für Geburtshilfe und Frauenheilkunde
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Department of Obstetrics and Gynaecology
Overview
Publications
(1,297)
Research Grants
(6)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Cost-effectiveness of pembrolizumab plus chemotherapy as first-line treatment in PD-L1-positive metastatic triple-negative breast cancer (2022)
Huang M, Fasching P, Haiderali A, Pan W, Gray E, Zhou ZY, Hu P, et al.
Journal article
Corrigendum to “A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study”: [Annals of Oncology (2019), volume 30:1279-1288, (Annals of Oncology (2019) 30(1279-1288) (S0923753419312785)) (2022)
Loibl S, Untch M, Burchardi N, Huober J, Sinn BV, Blohmer JU, Grischke EM, et al.
Journal article, Erratum
Ovarian tissue transplantations in 196 women by FertiPROTEKT- live birth rate of 26.5% per woman is associated with female age and first versus repeated transplantation (2022)
Lotz L, Bender-Liebenthron J, Dittrich R, Häberle L, Beckmann M, Germeyer A, Korell M, et al.
Conference contribution
COST EFFECTIVENESS OF PEMBROLIZUMAB COMBINED WITH CHEMOTHERAPY VS. CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR METASTATIC TNBC THAT EXPRESSES PD-L1 IN THE UNITED STATES (2022)
Huang M, Fasching P, Haiderali A, Pan W, Gray E, Zhou J, Hu PH, et al.
Conference contribution
Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment (2022)
Stübs F, Koch MC, Dietl A, Adler W, Geppert CI, Hartmann A, Knöll A, et al.
Journal article
External Beam Accelerated Partial Breast Irradiation in Early Breast Cancer and the Risk for Radiogenic Pneumonitis (2022)
Ott O, Stillkrieg W, Lambrecht U, Sauer TO, Schweizer C, Lamrani A, Strnad V, et al.
Journal article
Surgical treatment of endometrial cancer (2022)
Emons G, Brucker SY, Fleisch MC, Mueller M, Juhasz-Boess E, Kiesel L, Runnebaum IB, et al.
Journal article
Influence of Timing of Antenatal Corticosteroid Administration on Morbidity of Preterm Neonates (2022)
Morhart P, Gärtner J, Weiss C, Stumpfe F, Dammer U, Faschingbauer F, Fahlbusch F, et al.
Journal article
Quality assurance and improvement in oncology using guideline-derived quality indicators - results of gynaecological cancer centres certified by the German cancer society (DKG) (2022)
Griesshammer E, Wesselmann S, Beckmann M, Dannecker C, Wagner U, Sibert NT, Armbrust R, Sehouli J
Journal article
Update Breast Cancer 2022 Part 2 - Advanced Stage Breast Cancer (2022)
Müller V, Welslau M, Lüftner D, Schütz F, Stickeler E, Fasching P, Janni W, et al.
Journal article, Review article
‹
1
...
25
26
27
28
29
...
130
›